Daily Requirement of Oxygen to Reverse Pulmonary Hypertension in Patients with Chronic Bronchitis

Stark, R. D.; Finnegan, P.; Bishop, J. M.
September 1972
British Medical Journal;9/23/1972, Vol. 3 Issue 5829, p724
Academic Journal
No abstract available.


Related Articles

  • Treatment of pulmonary hypertension in chronic bronchitis and emphysema. Rees, John // British Medical Journal (Clinical Research Edition);11/24/1984, Vol. 289 Issue 6456, p1398 

    Examines the effectiveness of the treatment of pulmonary hypertension in chronic bronchitis and emphysema. Reduction of mortality in patients on the administration of oxygen; Effect of the treatment with Almitrine on blood concentrations; Manifestation of hemodynamic effects of nifedipine and...

  • United States : NEW drug sanctioned for COPD.  // TendersInfo News;8/6/2014, p1 

    The article reports that U.S. Food and Drug Administration has approved the once-daily bronchodilator inhalation spray olodaterol for treating patients with chronic obstructive pulmonary disease (COPD), emphysema and counting bronchitis.

  • Pulmonary hypertension from chronic pulmonary thromboembolism. Rich, Stuart; Levitzky, Sidney; Brundage, Bruce H.; Rich, S; Levitsky, S; Brundage, B H // Annals of Internal Medicine;Mar88, Vol. 108 Issue 3, p425 

    Pulmonary hypertension may develop whenever chronic obstruction of pulmonary arterial blood flow occurs. Although repeated pulmonary embolism is thought to be the usual underlying cause, there is little clinical evidence to support this theory. Studies of the pulmonary vascular endothelium have...

  • Pulmonary function in cases of stable chronic bronchitis. Huffman, Grace Brooke // American Family Physician;5/1/1998, Vol. 57 Issue 9, p2253 

    Examines the characteristics of chronic bronchitis previously outlined in `Effects of aerosolized surfactant in patients with stable chronic bronchitis. A prospective randomized controlled trial.' Details on the history of chronic bronchitis; Information on pulmonary function testing;...

  • Dasatinib.  // Reactions Weekly;10/5/2013, Issue 1472, p17 

    An abstract of the article "Reversible pulmonary hypertension as a consequence of dasatinib treatment in a patient with chronic myeloid leukemia and scleroderma," by R. Ryczek and colleagues is presented.

  • Reversal of experimental pulmonary hypertension by PDGF inhibition. Schermuly, Ralph Theo; Dony, Eva; Ghofrani, Hossein Ardeschir; Pullamsetti, Soni; Savai, Rajkumar; Roth, Markus; Sydykov, Akylbek; Ying Ju Lai; Weissmann, Norbert; Seeger, Werner; Grimminger, Friedrich // Journal of Clinical Investigation;Oct2005, Vol. 115 Issue 10, p2811 

    Progression of pulmonary hypertension is associated with increased proliferation and migration of pulmonary vascular smooth muscle cells. PDGF is a potent mitogen and involved in this process. We now report that the PDGF receptor antagonist STI571 (imatinib) reversed advanced pulmonary vascular...

  • New combination agent containing novel LABA approved for COPD. TANZI, MARIA G. // Pharmacy Today;Jul2015, Vol. 21 Issue 7, p40 

    The article discusses long-acting beta-2 agonist (LABA), olodaterol, has been approved by FDA in combination with tiotropium bromide, an anticholinergic (Stiolto Respimat—Boehringer Ingelheim), as a long-term maintenance treatment for patients with chronic obstructive pulmonary disease...

  • Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Abman, S.H. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2002, Vol. 87 Issue 1, pF15 

    In addition to persistent airways disease, survivors of premature birth with chronic lung disease are at risk of cardiovascular sequelae, including pulmonary hypertension, systemic hypertension, left ventricular hypertrophy, and exercise intolerance. The major treatment of pulmonary hypertension...

  • LETTERS TO THE EDITOR. Schachter, E. Neil; Beck, Gerald J.; Maunder, Lucinda R.; Schilling, Richard; Pratt, Philip C.; Cohen, Beverly S.; Harley, Naomi H. // Archives of Environmental Health;Sep/Oct80, Vol. 35 Issue 5 

    Comments on pulmonary pathology and public health. Inadequacy of information regarding the history of cigarette smoking; Problems concerning the statistical analysis of the authors; Contentions on the reversibility of chronic bronchitis.

  • Chronic bronchitis: Primary care management. Heath, John M.; Mongia, Rupa // American Family Physician;5/15/1998, Vol. 57 Issue 10, p2365 

    Focuses on optimal management of chronic bronchitis which is one of the main manifestations of chronic obstructive pulmonary disease. How chronic bronchitis is clinically diagnosed; Most effective way to reduce the risk of morbidity from chronic bronchitis; Patients who should be given oral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics